Literature DB >> 12796189

Short-term noninvasive pressure support ventilation prevents ICU admittance in patients with acute cardiogenic pulmonary edema.

Matteo Giacomini1, Gaetano Iapichino, Marco Cigada, Aldo Minuto, Rebecca Facchini, Andrea Noto, Elena Assi.   

Abstract

STUDY
OBJECTIVES: Noninvasive ventilation, although effective as treatment for patients with acute cardiogenic pulmonary edema when prolonged for hours, is of limited use in the emergency department (ED). The aim of the study was to determine whether a short attempt at noninvasive pressure support ventilation avoids ICU admittance and to identify lack of response prediction variables.
DESIGN: Prospective inception cohort study.
SETTING: ED of a university hospital. PATIENTS: Fifty-eight consecutive patients with cardiogenic pulmonary edema who had been unresponsive to medical treatment and were admitted between January 1999 and December 2000.
INTERVENTIONS: Pressure support ventilation was instituted through a full-face mask until the resolution of respiratory failure. A 15-min "weaning test" was performed to evaluate clinical stability. Responder patients were transferred to a medical ward. Nonresponding patients were intubated and were admitted to the ICU. MAIN OUTCOME MEASURES: The included optimal length of intervention, the avoidance of ICU admittance, the incidence of myocardial infarction, and predictive lack of response criteria.
RESULTS: Patients completed the trial (mean [+/- SD] duration, 96 +/- 40 min). None of the responders (43 patients; 74%) was subsequently ventilated or was admitted to the ICU. Two new episodes of myocardial infarction were observed. Thirteen of 58 patients died. A mean arterial pressure of < 95 mm Hg (odds ratio [OR], 10.6; 95% confidence interval [CI], 1.8 to 60.8; p < 0.01) and COPD (OR, 9.4; 95% CI, 1.6 to 54.0; p < 0.05) at baseline predicted the lack of response to noninvasive ventilation.
CONCLUSIONS: A short attempt at noninvasive ventilation is effective in preventing invasive assistance. A 15-min weaning test can identify patients who will not need further invasive ventilatory support. COPD and hypotension at baseline are negative predictive criteria.

Entities:  

Mesh:

Year:  2003        PMID: 12796189     DOI: 10.1378/chest.123.6.2057

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  5 in total

1.  Mortality in acute cardiogenic pulmonary edema treated with continuous positive airway pressure.

Authors:  Roberto Cosentini; Stefano Aliberti; Angelo Bignamini; Federico Piffer; Anna Maria Brambilla
Journal:  Intensive Care Med       Date:  2008-09-20       Impact factor: 17.440

2.  Changing use of noninvasive ventilation in critically ill patients: trends over 15 years in francophone countries.

Authors:  Alexandre Demoule; Sylvie Chevret; Annalisa Carlucci; Achille Kouatchet; Samir Jaber; Ferhat Meziani; Matthieu Schmidt; David Schnell; Céline Clergue; Jérôme Aboab; Antoine Rabbat; Béatrice Eon; Claude Guérin; Hugues Georges; Benjamin Zuber; Jean Dellamonica; Vincent Das; Joël Cousson; Didier Perez; Laurent Brochard; Elie Azoulay
Journal:  Intensive Care Med       Date:  2015-10-13       Impact factor: 17.440

3.  Parallel-group, randomised, controlled, non-inferiority trial of high-flow nasal cannula versus non-invasive ventilation for emergency patients with acute cardiogenic pulmonary oedema: study protocol.

Authors:  Onlak Ruangsomboon; Nattakarn Praphruetkit; Apichaya Monsomboon
Journal:  BMJ Open       Date:  2022-07-07       Impact factor: 3.006

Review 4.  Efficacy and safety of non-invasive ventilation in the treatment of acute cardiogenic pulmonary edema--a systematic review and meta-analysis.

Authors:  João C Winck; Luís F Azevedo; Altamiro Costa-Pereira; Massimo Antonelli; Jeremy C Wyatt
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

Review 5.  Clinical review: impact of emergency department care on intensive care unit costs.

Authors:  David T Huang
Journal:  Crit Care       Date:  2004-08-03       Impact factor: 9.097

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.